VisionGate Stock

visiongate3d.comHealthcareFounded: 1900Funding to Date: $49.27MM

VisionGate is a clinical stage oncology pharmaceutical and diagnostics company with a focus on the early detection and treatment of lung cancer and bronchial dysplasia.

Register for Details

For more details on financing and valuation for VisionGate, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for VisionGate.

Register Today

Team

Management Team

Michael Meyer
Chief Technology Officer
Randall Mastrangelo
Vice President, Global Commercial Strategy, Marketing and Sales
Vishu Jhaveri MD
Strategic Advisor
Randal Buness
Chief Financial Officer
Jon Hayenga
Vice President, Advanced Product Development
Javier Zulueta MD
Chief Medical Officer & Advisor, Medical
Alan Nelson Ph.D
Chief Executive Officer, Chairman & Founder
Scarlett Spring
President & Chief Commercial Officer
Chris Presley
Director of Clinical Research
Stephen Phillips
Vice President, Quality Systems

Board Members

James Burns
Reginald Ballantyne III
Thomas Miller
GreyBird Ventures
Alan Nelson Ph.D
Robert Heft Ph.D
Walter Robb
Maria Forero
Paul Kelly
Sharon Everson

Other companies like VisionGate in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM